ALHC Stock Analysis: Buy, Sell, or Hold?

ALHC - Alignment Healthcare, Inc. Common Stock

HOSPITAL & MEDICAL SERVICE PLANS
$14.85
-3.76 (-20.20%) β–Ό
5d: -23.57%
30d: -38.15%
90d: -34.12%
WAIT
LOW Confidence
Protect Your ALHC Gains
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Jul 30, 2026 0d

Get Alerted When ALHC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ALHC is down 23.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
See Forward Earnings Fair Value & Price Prediction β†’

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$35.17
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$21.84
32.0% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: ALHC is currently trading at $14.85, which is considered oversold relative to its 30-day fair value range of $18.90 to $23.15. From a valuation perspective, the stock is trading at a discount (Forward PE: 20.6) compared to its historical average (35.4). Remarkably, the market is currently pricing in an annual earnings decline of 16.6% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, ALHC is in a uptrend. Immediate support is located at $13.13, while resistance sits at $21.80. Short-term momentum is weak, with the stock down 20.2% recently.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $24.92 (+67.8%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $18.90 - $23.15
Company Quality Score 49/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 74.8%

Protect Your Profits

Holding ALHC? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-20.2%)
  • BULLISH: Trading 67.8% below Wall St target ($24.92)
  • WARNING: Recommendation downgraded due to -23.6% 5-day decline - wait for stabilization

Trading Range Analysis

30-Day Trading Range $18.90 - $23.15
Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $13.14
Resistance Level $21.80
Current Trend Uptrend
Technical data as of Jul 31, 2026

Fundamental Context

Forward P/E (Next Year Est.) 20.55
Wall Street Target $24.92 (+67.8%)
Revenue Growth (YoY) 33.3%
Profit Margin 0.5%
Valuation Discount vs History -16.6% cheaper
PE vs Historical 20.6 vs 35.4 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -16.6% (market-implied from PE analysis)
1-Year Target $13.36 (-10%)
2-Year Target $12.03 (-19%)
3-Year Target $10.83 (-27%)
3-Yr Target (if PE normalizes) (PE: 21β†’35) $18.65 (+26%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 20.7, Growth: 52.1%) $50.55 (+240%)
Base: (SPY PE: 20.6, Growth: 52.1%) $50.12 (+238%)
Bear: (PE: 17.5, Growth: 52.1%) $42.60 (+187%)
πŸ’‘ Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 20.6 to 35.4
Stabilization Target: $25.58 (+72.2%)
PE Expansion Potential: +72.2%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 02, 2026 4:53 PM ET
Data refreshes hourly during market hours. Next update: 5:53 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Dawn Christine Maroney SELL 30000 shares 2026-04-15
John E Kao SELL 82299 shares 2026-04-13
John E Kao SELL 215701 shares 2026-04-10

Unlock Insider Activity

See real-time buying/selling by company executives for ALHC.

Create Free Account

Already have an account? Log In

Top Rated Healthcare Plans Stocks

Top-rated stocks in Healthcare Plans by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
CVS
CVS Health Corp
STRONG BUY
28 analysts
$114 51 HOLD
UNH
UnitedHealth Group Incor…
STRONG BUY
27 analysts
$475 50 HOLD
CI
Cigna Corp
STRONG BUY
25 analysts
$343 47 HOLD
ELV
Elevance Health Inc
STRONG BUY
22 analysts
$449 55 HOLD
HUM
Humana Inc
HOLD
26 analysts
$408 54 HOLD

Advanced ALHC Option Strategies

Professional options setups generated by AI based on today's ALHC price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ALHC

ALHC Technical Chart ALHC Price Prediction ALHC Earnings Date ALHC Investment Advisor ALHC Fair Price Analyzer ALHC Options Advisor ALHC Options Chain ALHC Options Analysis ALHC Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals